- The trend backdrop is active with a 37-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
BAS
GER
Week ended 07 Aug 2026
Weekly Investor Report
BASF SE · Basic Materials · Chemicals
Latest close
51.50 EUR
2.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 5.9% above the Trend Line and sits at 80.6% of its 52-week range. The latest completed week returned 2.2%, after a 8.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
63
out of 100
Latest Close
51.50 EUR
7 Aug 2026
1W Return
2.2%
latest completed week
4W Return
8.3%
short-term follow-through
12W Return
-2.1%
quarterly tape
Trend Breadth
78.8%
41 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.2%
Latest completed week; four-week move 8.3%.
Indicator stack
88/43
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 5.9% above the Trend Line and sits at 80.6% of its 52-week range. The latest completed week returned 2.2%, after a 8.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4712-week average 0.71
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.47Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 8.3% over four weeks, -2.1% over 12 weeks, and 18.1% over one year. The current trend has remained active for 37 consecutive weeks.
Performance by holding period
Active trend streak37 weeks
Active weeks in one year41
Trend breadth78.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.62Latest activity-pressure read.
Pressure change45.0%Four-week change in activity pressure.
Leadership3.70Latest relative-leadership reading.
RS change170.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength57/100Blend of value, momentum, and quality. Underlying universe rank 44; rank 1 is best.
Value61/100Relative valuation strength. Underlying universe rank 40; rank 1 is best.
Quality20/100Profitability and accounting quality. Underlying universe rank 81; rank 1 is best.
Momentum64/100Medium-term price momentum. Underlying universe rank 37; rank 1 is best.
Growth39/100Revenue and earnings growth. Underlying universe rank 62; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework32/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 19.2x Price divided by trailing earnings.
- Price / sales
- 0.7x Market value relative to trailing revenue.
- EV / EBITDA
- 8.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -0.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 25.0% Gross profit retained from each unit of revenue.
- Operating margin
- 6.4% Operating profit retained from revenue.
- Free-cash-flow margin
- -0.7% Free cash flow generated from revenue.
- Return on invested capital
- 5.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -2.9% Latest one-year revenue growth.
- EPS growth
- 24.7% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 79.5% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 4.4% Cash dividends relative to market value.
- Buyback yield
- 1.9% Net share repurchases relative to market value.
- Shareholder yield
- 6.2% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.2%Distance below the 52-week high.
13-week volatility1.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+13.3%Week of 27 Mar.
Worst week-7.0%Week of 6 Mar.
Latest week+2.2%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains9
Flat weeks0
Modest losses10
Sharp losses3
Recent vol1.9%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Basic Materials
4-week rank13 / 44
Group average3.5%
Trend breadth47.7%
Trend47.7%active weekly trend signals
MD20.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryDE Chemicals
4-week rank1 / 3
Group average5.9%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD0.0%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape63/100
Trend, activity pressure, participation, and risk combine to a 63/100 tape read.
Indicator analysis62/100Latest 12-week confirmation: trend 12/12, activity pressure 4/12, relative leadership 11/12.
Activity pressure 0.47; 2 reversal markers Factors49/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 21; Small Cap Core rank 34 SVQF32/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 253.5 of 375 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
BASF SE: Release of a capital market information Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 51.50 EUR | 2.2% | 48.62 EUR | 42.41 EUR | -0.62 | 3.70 | 7.9M | On |
| 31 Jul 2026 | 50.40 EUR | 3.8% | 48.34 EUR | 42.34 EUR | -0.81 | 4.38 | 11.3M | On |
| 24 Jul 2026 | 48.57 EUR | 0.1% | 48.09 EUR | 42.27 EUR | -1.01 | 2.98 | 9.5M | On |
| 17 Jul 2026 | 48.54 EUR | 2.1% | 47.86 EUR | 42.23 EUR | -1.09 | 4.18 | 11.5M | On |
| 10 Jul 2026 | 47.55 EUR | -0.5% | 47.64 EUR | 42.18 EUR | -1.12 | 1.37 | 8.2M | On |
| 3 Jul 2026 | 47.78 EUR | 0.0% | 47.49 EUR | 42.12 EUR | -0.94 | -0.77 | 1.3M | On |
| 26 Jun 2026 | 47.76 EUR | -2.5% | 47.30 EUR | 42.06 EUR | -0.62 | 3.83 | 1.9M | On |
| 19 Jun 2026 | 49.01 EUR | -1.0% | 47.14 EUR | 42.00 EUR | -0.23 | 5.44 | 6.4M | On |
| 12 Jun 2026 | 49.50 EUR | -2.9% | 46.91 EUR | 41.91 EUR | 0.13 | 8.31 | 2.3M | On |
| 5 Jun 2026 | 50.98 EUR | 0.3% | 46.65 EUR | 41.84 EUR | 0.44 | 11.33 | 2.0M | On |
| 29 May 2026 | 50.82 EUR | -1.6% | 46.30 EUR | 41.77 EUR | 0.76 | 9.92 | 12.4M | On |
| 22 May 2026 | 51.67 EUR | -1.8% | 45.98 EUR | 41.70 EUR | 0.88 | 13.11 | 12.7M | On |
| 15 May 2026 | 52.63 EUR | 1.9% | 45.65 EUR | 41.62 EUR | 0.99 | 20.23 | 13.0M | On |
| 8 May 2026 | 51.65 EUR | -1.6% | 45.29 EUR | 41.54 EUR | 1.05 | 16.66 | 20.9M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.